OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis
Hiroyuki Akamine, Akiyuki Uzawa, Yuta Kojima, et al.
Journal of Neuroimmunology (2023) Vol. 375, pp. 578014-578014
Closed Access | Times Cited: 3
Hiroyuki Akamine, Akiyuki Uzawa, Yuta Kojima, et al.
Journal of Neuroimmunology (2023) Vol. 375, pp. 578014-578014
Closed Access | Times Cited: 3
Showing 3 citing articles:
Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives
Jiayan Huang, Yan Zhao, Yafang Song, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 651-651
Open Access | Times Cited: 6
Jiayan Huang, Yan Zhao, Yafang Song, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 651-651
Open Access | Times Cited: 6
Identification and characteristics of a novel CD8αα T cell subset in a refractory myasthenia gravis patient
Yujia Liu, Hanxiao Sun, Yingchen Xu, et al.
Journal of Neuroimmunology (2025) Vol. 400, pp. 578551-578551
Closed Access
Yujia Liu, Hanxiao Sun, Yingchen Xu, et al.
Journal of Neuroimmunology (2025) Vol. 400, pp. 578551-578551
Closed Access
Azithromycin downregulates ICOS (CD278) and OX40 (CD134) expression and mTOR activity of TCR-activated T cells to inhibit proliferation
Abdul W. Ansari, Fareed Ahmad, Thesni Raheed, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110831-110831
Open Access | Times Cited: 3
Abdul W. Ansari, Fareed Ahmad, Thesni Raheed, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110831-110831
Open Access | Times Cited: 3
